Hemostatics Pharmaceuticals S.L.
PrivateLast Round
Grant
Nov 1, 2023
Total Funding Raised
$3.4M
Company Overview
Hemostatics Pharmaceuticals S.L. is a biotechnology company that develops novel antifibrinolytic agents, including its lead preclinical candidate CM-352, to reduce bleeding in life-threatening and disabling hemorrhagic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemostatics Pharmaceuticals S.L. Comparables
Compare Hemostatics Pharmaceuticals S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioxodes | 86% | |
| Cayuga Biotech | 82% | |
| Haima Therapeutics | 77% |
Hemostatics Pharmaceuticals S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2023 | ||||
| Seed | May 12, 2021 |
Key People
Founding team and executive leadership
Hemostatics Pharmaceuticals S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agencia Estatal de Investigación | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2023
$1.09M grant received from Agencia Estatal de Investigación.
- May 12, 2021
$2M raised in Seed round.
Hemostatics Pharmaceuticals S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hemostatics Pharmaceuticals S.L.'s valuation, stock price, and market status.
Is Hemostatics Pharmaceuticals S.L. a public or private company?
Hemostatics Pharmaceuticals S.L. is a private company.
What is the current stock price of Hemostatics Pharmaceuticals S.L.?
Hemostatics Pharmaceuticals S.L. is a private company with no public stock price. No recent secondary market data is available.
How much is Hemostatics Pharmaceuticals S.L. worth (valuation)?
Valuation information for Hemostatics Pharmaceuticals S.L. is not publicly available.
Can I buy Hemostatics Pharmaceuticals S.L. stock?
Hemostatics Pharmaceuticals S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hemostatics Pharmaceuticals S.L.'s last funding round?
Hemostatics Pharmaceuticals S.L.'s most recent funding round was Grant on November 1, 2023.
Who are the main investors in Hemostatics Pharmaceuticals S.L.?
Key investors in Hemostatics Pharmaceuticals S.L. include Agencia Estatal de Investigación.
Will Hemostatics Pharmaceuticals S.L. IPO soon?
No public IPO plans have been announced for Hemostatics Pharmaceuticals S.L..
How can I track Hemostatics Pharmaceuticals S.L. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemostatics Pharmaceuticals S.L.'s secondary market activity and sign up for updates.